While no SAEs were seen in our cohort, some complained about mild gastrointestinal AEs
Within the GLP-1RA group, discontinuing treatment for even 0.5 years was associated with a higher MACE risk compared to continued use
These microorganisms produce compounds that stimulate the release of GLP-1, enhancing your body's natural appetite regulation system
Key findings: weight loss, safety & tolerability, discontinuation The research revealed several significant insights: Greater weight loss with tirzepatide: Most adults with overweight or obesity experienced 5% or greater weight loss with either treatment
Efficacy of Liraglutide in Non-Diabetic Obese Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Products discussed include Pendulum Glucose Control , Pendulum GLP-1 Probiotic , and Bioma Gut Health Probiotics